Johannes Belmar
Publications by Year
Research Areas
Chronic Myeloid Leukemia Treatments, Cancer therapeutics and mechanisms, Synthesis and Characterization of Heterocyclic Compounds, Synthesis and biological activity, Cell death mechanisms and regulation
Most-Cited Works
- → Small molecule Mcl-1 inhibitors for the treatment of cancer(2014)179 cited
- → Discovery of 2-Indole-acylsulfonamide Myeloid Cell Leukemia 1 (Mcl-1) Inhibitors Using Fragment-Based Methods(2016)144 cited
- → Total Synthesis of (±)-Communesin F via a Cycloaddition with Indol-2-one(2012)113 cited
- → Discovery of Tricyclic Indoles That Potently Inhibit Mcl-1 Using Fragment-Based Methods and Structure-Based Design(2015)95 cited
- → Optimization of Potent and Selective Tricyclic Indole Diazepinone Myeloid Cell Leukemia-1 Inhibitors Using Structure-Based Design(2018)64 cited
- → Discovery and biological characterization of potent myeloid cell leukemia‐1 inhibitors(2016)61 cited
- → Structure of a Myeloid cell leukemia-1 (Mcl-1) inhibitor bound to drug site 3 of Human Serum Albumin(2017)19 cited
- → Total synthesis of (±)-isophellibiline(2011)10 cited
- → CCDC 2023739: Experimental Crystal Structure Determination(2020)
- → Abstract 4331: Discovery of potent 2-Indole-acylsulfonamide Mcl-1 inhibitors using structure guided fragment-based methods(2016)